02428nam 2200625 a 450 991077865410332120230421033227.00-309-17652-21-280-19299-297866101929910-309-58791-30-585-02541-X(CKB)110986584751598(SSID)ssj0000137964(PQKBManifestationID)11146785(PQKBTitleCode)TC0000137964(PQKBWorkID)10096668(PQKB)10945348(Au-PeEL)EBL3376237(CaPaEBR)ebr10055260(OCoLC)923262252(MiAaPQ)EBC3376237(EXLCZ)9911098658475159819950206d1995 uy 0engurcn|||||||||txtccrDevelopment of medications for the treatment of opiate and cocaine addictions[electronic resource] issues for the government and private sector /Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of MedicineWashington, DC National Academy Press1995xvii, 250 p. illCommittee chairman: Laurence E. Earley.Support for this study was provided by the National Institute on Drug Abuse.0-309-05244-0 Includes bibliographical references.Drug addictionTreatmentCocaine abuseTreatmentSubstance abuseTreatmentDrug addictionTreatment.Cocaine abuseTreatment.Substance abuseTreatment.616.86/32061Fulco Carolyn1474191Liverman Catharyn T1086332Earley Laurence E1522892National Institute on Drug Abuse.Committee to Study Medication Development and Research.Institute of Medicine (U.S.).Division of Biobehavioral Sciences and Mental Disorders.MiAaPQMiAaPQMiAaPQBOOK9910778654103321Development of medications for the treatment of opiate and cocaine addictions3853695UNINA